Competitive Positioning of BTK Inhibitors in Combination Therapies
The integration of BTK inhibitors into combination therapies is rapidly evolving. As new combinations are explored, they promise to improve treatment outcomes for patients with a variety of cancers and autoimmune diseases, positioning BTK inhibitors as a cornerstone in modern medical treat